Navigation Links
Daytrana in Medical News

New analysis shows DAYTRANA offered ADHD symptom control for 12 months

Washington, D.C. May 7, 2008 Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced findings from a new data analysis that was conducted to examine treatment differences with DAYTRANA (methylphenidate transdermal system) between boys and girls aged 6...

Long-term 12-month safety data on ADHD patch DAYTRANA

BOSTON OCTOBER 25, 2007 Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, announced that data from a 12-month study of DAYTRANATM (methylphenidate transdermal system), the Attention Deficit Hyperactivity Disorder (ADHD) patch, demonstrated that DAYTRA...

Shire Developed DAYTRANA – The First Medication to Treat ADHD Symptom

DAYTRANA (methylphenidate transdermal system), formulated by Shire was the foremost patch medication approved to treat symptoms of ADHD in children//. Transdermal formulation of methylphenidate - DAYTRANA, is now available in pharmacies in varying doses such as 10 mg, 15 mg, 20 mg and 30 mg. ...

Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced

.../recall of thirty-nine (39) lots of the ADHD patch daytrana (the lots of daytrana patches affected by this action are listed below). Shire is taking this action because some daytrana patches no longer meet their release liner removal...

Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track

... 10.6(3) n/a n/a 2% daytrana 9.4 -5% 64% ...to be recognized into revenue by the end of 2007. daytrana - ADHD DAYTRANA's average share of the US ADHD ma...the US ADHD market resulted in US prescriptions of daytrana for the three months to September 30, 2007 being u...

Shire to Present New Scientific Data on its ADHD Treatments at a Major Psychiatric Meeting

...e Effect Size in Children with ADHD Poster# E58 daytrana (methylphenidate transdermal system): October 25...Information go to http://www.vyvanse.com . About daytrana Tell your doctor about any heart conditions, incl...t heart problems, such as chest pain or fainting. daytrana should not be used if the child has: significant a...
Daytrana in Medical Technology

Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)

...m) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). A request from European regulators to conduct an additional clinical study on daytrana in a European patient population combined with the recently announced planned acquisition of the worldwide rights (excluding the US, Canada and Barbad...

New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months

...D). The findings from the analysis reaffirmed that daytrana has an established safety profile and effectively ...n, D.C. "This analysis further demonstrates that daytrana has a recognized safety profile and is an effectiv... decreased weight. In the study, the efficacy of daytrana was measured using the ADHD Rating Scale (ADHD-RS-...

Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system)

...ractivity Disorder (ADHD) patch, demonstrated that daytrana provided significant ADHD tolerability and symptom...ective ADHD symptom control improvement when using daytrana for 12 months, improving their ability to maintain...a. "Importantly, this year- long study showed that daytrana maintained a favorable safety profile throughout t...

Shire to Present New Scientific Data on ADHD Treatment Portfolio at APA Annual Meeting

...ctivity Disorder APA Poster# NR750 daytrana (methylphenidate transdermal system): May 23...tite, insomnia, headache, and weight loss. About daytrana daytrana should not be used in patients with allergy to met...

12-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA (methylphenidate transdermal system)

...D experienced effective ADHD treatment with use of daytrana for 12 months, sustaining the improvements in thei... Pittsburgh School of Medicine. "More importantly, daytrana maintained a favorable safety profile, meeting the... and other stimulants in this class." Shire's daytrana is the first and only patch medication approved by...

Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls

...agnosed and, therefore, undertreated. Shire's daytrana is the first and only patch medication approved by...e symptoms of ADHD in children aged 6 to 12 years. daytrana is available in four dosage strengths - 10 mg, 15 ...dy's primary endpoint. The 58 boys that received daytrana averaged a significant 56 percent ADHD- RS-IV tota...
Daytrana in Biological Technology

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

... 67.4 -77% -77% -48% 11.0% daytrana 14.9 -34% -34% ...ADDERALL XR to Teva in the URA calculation. daytrana - ADHD Product sales of daytrana for the three months to June 30, 2009 decreased by...

Shire begins the year with a strong performance

...-promotion of LIALDA in the US. Pipeline daytrana - for the treatment of ADHD in children in the EU ...he MAA does not impact Shire's commitment to daytrana in the US where the product has been used as...the US in the fourth quarter of 2009; - daytrana for the treatment of ADHD in adolescents in the US...

Publication of Shire plc's Annual Report 2008

...VANT in certain EU countries; - the launch of daytrana (EU and Canada); - the continued roll out of ...oval; six in the US (FOSRENOL and EQUETRO in 2004, daytrana and ELAPRASE in 2006, LIALDA and VYVANSE in 2007) ...atory filing for VYVANSE in Europe in 2010. daytrana for ADHD in EU & Canada Regulatory subm...

Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion

...ucting additional clinical outcomes trials; - daytrana (methylphenidate transdermal system) for use in th... 318.9 +317% +388% 8.2% daytrana 78.7 +23% -11% ...n 2007) and a price increase in April 2008. daytrana - ADHD Product sales for the year to Decemb...

Shire's New Product Portfolio Delivers Strong Quarterly Performance

... 96.0 806% n/a 9.0% daytrana 18.1 93% -14% ... of 10.2%, based on weekly prescription volumes. daytrana - ADHD Product sales for the three months to Sep... of DAYTRANA. No interruption in the production of daytrana is anticipated. Shire and Noven may take additiona...

Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade.

... 65.2 n/a n/a 7.4% daytrana 22.6 14% -11% ...re of 8.2% based on weekly prescription volumes. daytrana - ADHD Product sales for the three months to Jun...nounced a voluntary recall of a limited portion of daytrana patches because certain patches did not meet their...

Non-Safety-Related Voluntary Recall of a Limited Portion of DAYTRANA(TM) (Methylphenidate Transdermal System) Patches Announced

...voluntary recall of two (2) lots of the ADHD patch daytrana (lots 2750211 and 2764111). Shire is taking this a...while being opened. The current supply levels of daytrana should be sufficient to ensure that patients can continue to have their daytrana prescriptions filled at their local pharmacy. Nove...

Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance

...have difficulty removing the release liner of some daytrana patches, similar to the concerns which led to a voluntary market withdrawal of a limited number of daytrana patches in September 2007. Shire and Noven continu...for use in adult patients in the US in Q2 2008; - daytrana in the EU during H1 2009; - INTUNIV in the US dur...

Shire plc: IFRS Results for the Year Ending December 31, 2007

... 76.5 - N/A N/A daytrana 64.2 25.1 +156 +...to revenue during the year to December 31, 2007. daytrana - ADHD Product sales for the year to December 31...NA was launched in June 2006). US prescriptions of daytrana for the year to December 31, 2007 over 2006 benefi...

Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%

...nto new geographies. These products, together with daytrana that was launched last year, represented 32% of ou... patients, of which 7.5 million are untreated. - daytrana - ADHD - Regulatory submissions were filed for app...US in Q2 2008 (PDUFA date April 28, 2008); - daytrana in the EU during H1 2009; - INTUNIV in the US dur...
Other Tags
(Date:5/4/2015)... NY (PRWEB) May 04, 2015 ... insurance programs, announces the expansion of coverage for its ... a leading provider of industry-tailored insurance and proactive risk ... & Company, we are dedicated to providing our customers ... meet their many evolving needs. We are excited to ...
(Date:5/4/2015)... TROY Healthcare Solutions is proud to be a ... (RUG) Conference in Baltimore, MD from May 11 – ... provides an opportunity for clients to gather to network, ... In addition to sponsoring the event, TROY Healthcare Solutions ... Conference. Attendees can stop by the TROY booth and ...
(Date:5/4/2015)... May 04, 2015 Baptist Medical ... Stroke Association’s Get With The Guidelines®-Stroke Gold Plus ... Honor Roll. The award recognizes the hospital’s commitment ... the most appropriate treatment according to nationally recognized, ... , To receive the Gold Plus Quality Achievement ...
(Date:5/4/2015)... May 04, 2015 Now in its ... clinical leaders who have made outstanding contributions to the ... serve, both in acute and post-acute care settings. The ... Post-Acute Provider of the Year, Advanced Practice Clinician of ... Provider of the Year. Recipients are selected by IPC’s ...
(Date:5/4/2015)... May 04, 2015 Los Angeles ... offering a more comfortable and attractive alternative for patients ... choice for those who have lost teeth. Unfortunately, they ... insecure or slip at the worst possible moment and ... talks. They can also painfully pinch or rub gums, ...
Breaking Medicine News(10 mins):Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 2Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 3Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 3Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 2Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 3Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 4Health News:IPC Healthcare Announces Clinicians of the Year 2Health News:IPC Healthcare Announces Clinicians of the Year 3Health News:Los Angeles Dental Implants Doctor, Kevin Sands DDS, Now Offers a More Comfortable and Aesthetically-Pleasing Solution to Denture-Wearers 2
(Date:4/1/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... mobile commerce market, announces the second shipment of a ... early access pre-order customers. Feedback from ... including Walmart, Target, AT&T, Dunkin, Donuts, Stop & Shop ... all outlets and very easy to use. Several users ...
(Date:3/31/2015)... --  Guidepoint , a leading global research services firm, ... TRACKER, part of the Guidepoint TRACKER suite ... device and therapeutics markets. The Post-Surgical Pain Management TRACKER ... share, and adoption rates across three major modalities used ... The Post-Surgical Pain Management TRACKER will provide length ...
(Date:3/24/2015)... , Mar. 24, 2015 Research and Markets ... of the "Global Iris Recognition Market 2015-2019" ... the Global Iris Recognition market to grow at a ... This report covers the present scenario and the ... the period 2015-2019. To calculate the market size, the ...
Breaking Biology News(10 mins):NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2
Other Contents